Dr John Willan
Supernumery Fellow in Clinical Medicine.
Chair of the Haematology Registrars Forum - Oxford University NHS Foundation Trust.
Member of the Medical Registrars Forum – Oxford University NHS Foundation Trust
BA (Cantab), BM BCh (Oxon), DPhil (Oxon), MRCP, FRCPath
I am the Fellow of Clinical Medicine at Brasenose and so am responsible for coordinating, and delivering the college based teaching to students in their clinical years. As the numbers of clinical students in each year are relatively small, I am able to get to know the students well, and I aim to tailor the teaching that is delivered to the needs of the individual students, giving many of the tutorials myself, but also calling on a large network of clinicians affiliated to the college to ensure specialist teaching can be provided as needed.
I have been involved in clinical medicine teaching for many years, previously working as an external tutor of clinical medicine at Magdalen College (2009-2016).
In my role as a clinical haematologist I am heavily involved in the investigation, diagnosis and treatment of patients with haematological disease, especially malignancies such as leukaemia and lymphoma. These patients may often require very intensive treatment (including combination chemotherapy and bone marrow transplantation), and so managing them requires astute clinical acumen, and keeps me involved with all the different fields of medicine. I also manage patients with other haematological diseases such as sickle cell disease, haemophilia and thrombophilia.
I am mostly involved in teaching clinical medicine, though am happy to deliver pre-clinical tutorials as time allows.
Clinical medicine, including bed side examination in all areas of medicine and surgery, communication skills, radiology, blood test interpretation, ECGs etc
Although I am a full time clinician, I have a strong interest in severe haemophilia, and am developing a web-based tool to enhance patient management. This project has recently won a local innovation award to support this, and to enable its development and introduction at centres around the country.
Multiple myeloma in the very elderly patient. Challenges and solutions. Willan et al. Clin Interv Aging, 2016